Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Bone and Mineral Metabolism
Metadata
Title
Factors associated with mortality following hip fracture in Japan
Authors
Shigeyuki Muraki
Seizo Yamamoto
Hideaki Ishibashi
Kozo Nakamura
Publication date
01-03-2006
Publisher
Springer-Verlag
Published in
Journal of Bone and Mineral Metabolism / Issue 2/2006
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-005-0654-z

Other articles of this Issue 2/2006

Journal of Bone and Mineral Metabolism 2/2006 Go to the issue

MINI REVIEW

Physiological role of bone morphogenetic proteins in osteogenesis

ORIGINAL ARTICLE

Increased prevalence of peripheral arterial disease in osteoporotic postmenopausal women

REVIEW ARTICLE

Renal osteodystrophy for nonnephrologists

ORIGINAL ARTICLE

CA repeat polymorphism of the TNFR2 gene is not associated with bone mineral density in two independent Caucasian populations

SHORT COMMUNICATION

Use of the SST–REX method for the identification of genes expressed at the condensation stage of chondrogenic cell line ATDC5

ORIGINAL ARTICLE

Secondary hyperparathyroidism as a palpable intrathyroid parathyroid gland in a patient with hypophosphatemic osteomalacia

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits